ACI Formulations (DHA:ACIFORMULA) Interest Expense : BDT-291 Mil (TTM As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ACI Formulations's interest expense for the three months ended in Dec. 2023 was BDT -68 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was BDT-291 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ACI Formulations's Operating Income for the three months ended in Dec. 2023 was BDT 235 Mil. ACI Formulations's Interest Expense for the three months ended in Dec. 2023 was BDT -68 Mil. ACI Formulations's Interest Coverage for the quarter that ended in Dec. 2023 was 3.48. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ACI Formulations Interest Expense Historical Data

The historical data trend for ACI Formulations's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Interest Expense Chart

ACI Formulations Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-234.62

-222.46

-129.33

-133.09

-259.20

ACI Formulations Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-52.82	-66.44	-100.61	-56.57	-67.67

ACI Formulations Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-291 Mil.

ACI Formulations (DHA:ACIFORMULA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ACI Formulations's Interest Expense for the three months ended in Dec. 2023 was BDT-68 Mil. Its Operating Income for the three months ended in Dec. 2023 was BDT235 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was BDT25 Mil.

ACI Formulations's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	235.287	/	-67.666
	=	3.48

The higher the ratio, the stronger the company's financial strength is.

ACI Formulations (DHA:ACIFORMULA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.aci-bd.com

ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines